DI DONNA, MARTINA GAIA
 Distribuzione geografica
Continente #
NA - Nord America 112
EU - Europa 108
AS - Asia 105
SA - Sud America 15
AF - Africa 7
Totale 347
Nazione #
US - Stati Uniti d'America 109
IT - Italia 62
SG - Singapore 60
CN - Cina 13
BR - Brasile 12
JP - Giappone 10
GB - Regno Unito 9
RU - Federazione Russa 9
FI - Finlandia 8
VN - Vietnam 8
HK - Hong Kong 7
DE - Germania 6
NL - Olanda 4
PL - Polonia 4
AR - Argentina 2
CA - Canada 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
FR - Francia 1
KE - Kenya 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 347
Città #
Singapore 31
Rome 24
San Jose 24
Council Bluffs 13
Tokyo 10
Ashburn 9
Helsinki 6
Hong Kong 6
Beijing 5
Milan 5
Los Angeles 4
Munich 4
Pieve a Nievole 4
Warsaw 4
Buffalo 3
Chicago 3
Houston 3
London 3
Poplar 3
Brescia 2
Frankfurt am Main 2
Hanoi 2
Ho Chi Minh City 2
Johannesburg 2
New York 2
North Bergen 2
Salt Lake City 2
São Paulo 2
The Dalles 2
Atlanta 1
Belo Horizonte 1
Biên Hòa 1
Buenos Aires 1
Caldas Novas 1
Calgary 1
Campinas 1
Casablanca 1
Charleston 1
Copenhagen 1
Curitiba 1
Dakar 1
Dallas 1
Denver 1
Francisco I. Madero Municipality 1
Ha Long 1
Haiphong 1
Hampton 1
Jaguariúna 1
Kansas City 1
Lappeenranta 1
Lauterbourg 1
Londrina 1
Lusciano 1
Manchester 1
Marsala 1
Miguel Pereira 1
Montreal 1
Moscow 1
Muscat 1
Nairobi 1
Nueva Esperanza 1
Parsippany 1
Petaling Jaya 1
Philadelphia 1
Phoenix 1
Pittsburgh 1
Quezon City 1
Redondo Beach 1
Rio Branco 1
San Francisco 1
San Luis 1
Santa Cruz do Sul 1
Senador Firmino 1
Seoul 1
Sousse 1
Tallinn 1
Tashkent 1
Tiraspol 1
Torre Boldone 1
Turku 1
Winchester 1
Yinchuan 1
Totale 237
Nome #
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease 99
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study 90
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease 57
Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease 30
Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies” 25
Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies 24
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. 21
Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit 18
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection 16
Totale 380
Categoria #
all - tutte 912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202574 0 0 0 0 4 7 18 5 4 11 12 13
2025/2026306 10 4 14 22 37 14 45 27 80 53 0 0
Totale 380